CIAM
ALT icon

Caitong International Asset Management’s Altimmune ALT Stock Holding History

Caitong International Asset Management’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$53K Buy
17,217
+15,293
+795% +$64.9K 0.01% 767
2025
Q4 		$6.95K Buy
+1,924
New +$8.39K ﹤0.01% 1197
2025
Q3 		– Sell
-239,630
Closed -$927K – 1905
2025
Q2 		$927K Buy
239,630
+238,693
+25,474% +$1.29M 0.66% 27
2025
Q1 		$4.68K Sell
937
-23,399
-96% -$148K ﹤0.01% 1039
2024
Q4 		$175K Buy
+24,336
New +$186K 0.17% 108

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Caitong International Asset Management's ALT Position: Q1 2026 in Review

Caitong International Asset Management increased its Altimmune (ALT) stake by 795% in Q1 2026, buying an estimated $64.9K and bringing the position to 17,217 shares worth $53K. The position accounts for 0.01% of the portfolio, ranked #767.

Caitong International Asset Management first reported a position in ALT in Q4 2024 and has held it in 5 quarters since. The position peaked at $927K in Q2 2025. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

  • Caitong International Asset Management held 17,217 shares of Altimmune worth $53K as of Q1 2026.
  • Caitong International Asset Management bought 15,293 Altimmune shares in Q1 2026, an estimated $64.9K.
  • Altimmune made up 0.01% of Caitong International Asset Management's portfolio in Q1 2026, its #767 holding.
  • Caitong International Asset Management first reported a position in Altimmune in Q4 2024 and has held it in 5 quarters since.
  • Caitong International Asset Management's Altimmune position peaked at $927K in Q2 2025.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.